The global Glipizide Controlled Release Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
2.5mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glipizide Controlled Release Tablet include Pfizer, Teva, NOVARTIS, Beijing Tianan, Hainan Jinxiao, Shanghai Xinyi, Zhuhai Federation, Changzhou Siyao Pharmaceutical and Disa Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
The glipizide controlled release tablet is a drug suitable for patients with mild and moderate type 2 diabetes who cannot be satisfactorily controlled by diet therapy alone.
This report aims to provide a comprehensive presentation of the global market for Glipizide Controlled Release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glipizide Controlled Release Tablet. This report contains market size and forecasts of Glipizide Controlled Release Tablet in global, including the following market information:
Global Glipizide Controlled Release Tablet Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glipizide Controlled Release Tablet Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glipizide Controlled Release Tablet companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glipizide Controlled Release Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glipizide Controlled Release Tablet Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glipizide Controlled Release Tablet Market Segment Percentages, by Type, 2022 (%)
2.5mg
5mg
10mg
Global Glipizide Controlled Release Tablet Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glipizide Controlled Release Tablet Market Segment Percentages, by Application, 2022 (%)
Medical
Research Laboratories
Others
Global Glipizide Controlled Release Tablet Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glipizide Controlled Release Tablet Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glipizide Controlled Release Tablet revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glipizide Controlled Release Tablet revenues share in global market, 2022 (%)
Key companies Glipizide Controlled Release Tablet sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glipizide Controlled Release Tablet sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva
NOVARTIS
Beijing Tianan
Hainan Jinxiao
Shanghai Xinyi
Zhuhai Federation
Changzhou Siyao Pharmaceutical
Disa Pharmaceutical
Walvax
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glipizide Controlled Release Tablet, market overview.
Chapter 2: Global Glipizide Controlled Release Tablet market size in revenue and volume.
Chapter 3: Detailed analysis of Glipizide Controlled Release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glipizide Controlled Release Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glipizide Controlled Release Tablet capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Glipizide Controlled Release Tablet Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glipizide Controlled Release Tablet Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glipizide Controlled Release Tablet Overall Market Size
2.1 Global Glipizide Controlled Release Tablet Market Size: 2022 VS 2029
2.2 Global Glipizide Controlled Release Tablet Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glipizide Controlled Release Tablet Sales: 2018-2029
3 Company Landscape
3.1 Top Glipizide Controlled Release Tablet Players in Global Market
3.2 Top Global Glipizide Controlled Release Tablet Companies Ranked by Revenue
3.3 Global Glipizide Controlled Release Tablet Revenue by Companies
3.4 Global Glipizide Controlled Release Tablet Sales by Companies
3.5 Global Glipizide Controlled Release Tablet Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glipizide Controlled Release Tablet Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glipizide Controlled Release Tablet Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glipizide Controlled Release Tablet Players in Global Market
3.8.1 List of Global Tier 1 Glipizide Controlled Release Tablet Companies
3.8.2 List of Global Tier 2 and Tier 3 Glipizide Controlled Release Tablet Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Glipizide Controlled Release Tablet Market Size Markets, 2022 & 2029
4.1.2 2.5mg
4.1.3 5mg
4.1.4 10mg
4.2 By Type - Global Glipizide Controlled Release Tablet Revenue & Forecasts
4.2.1 By Type - Global Glipizide Controlled Release Tablet Revenue, 2018-2023
4.2.2 By Type - Global Glipizide Controlled Release Tablet Revenue, 2024-2029
4.2.3 By Type - Global Glipizide Controlled Release Tablet Revenue Market Share, 2018-2029
4.3 By Type - Global Glipizide Controlled Release Tablet Sales & Forecasts
4.3.1 By Type - Global Glipizide Controlled Release Tablet Sales, 2018-2023
4.3.2 By Type - Global Glipizide Controlled Release Tablet Sales, 2024-2029
4.3.3 By Type - Global Glipizide Controlled Release Tablet Sales Market Share, 2018-2029
4.4 By Type - Global Glipizide Controlled Release Tablet Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glipizide Controlled Release Tablet Market Size, 2022 & 2029
5.1.2 Medical
5.1.3 Research Laboratories
5.1.4 Others
5.2 By Application - Global Glipizide Controlled Release Tablet Revenue & Forecasts
5.2.1 By Application - Global Glipizide Controlled Release Tablet Revenue, 2018-2023
5.2.2 By Application - Global Glipizide Controlled Release Tablet Revenue, 2024-2029
5.2.3 By Application - Global Glipizide Controlled Release Tablet Revenue Market Share, 2018-2029
5.3 By Application - Global Glipizide Controlled Release Tablet Sales & Forecasts
5.3.1 By Application - Global Glipizide Controlled Release Tablet Sales, 2018-2023
5.3.2 By Application - Global Glipizide Controlled Release Tablet Sales, 2024-2029
5.3.3 By Application - Global Glipizide Controlled Release Tablet Sales Market Share, 2018-2029
5.4 By Application - Global Glipizide Controlled Release Tablet Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Glipizide Controlled Release Tablet Market Size, 2022 & 2029
6.2 By Region - Global Glipizide Controlled Release Tablet Revenue & Forecasts
6.2.1 By Region - Global Glipizide Controlled Release Tablet Revenue, 2018-2023
6.2.2 By Region - Global Glipizide Controlled Release Tablet Revenue, 2024-2029
6.2.3 By Region - Global Glipizide Controlled Release Tablet Revenue Market Share, 2018-2029
6.3 By Region - Global Glipizide Controlled Release Tablet Sales & Forecasts
6.3.1 By Region - Global Glipizide Controlled Release Tablet Sales, 2018-2023
6.3.2 By Region - Global Glipizide Controlled Release Tablet Sales, 2024-2029
6.3.3 By Region - Global Glipizide Controlled Release Tablet Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Glipizide Controlled Release Tablet Revenue, 2018-2029
6.4.2 By Country - North America Glipizide Controlled Release Tablet Sales, 2018-2029
6.4.3 US Glipizide Controlled Release Tablet Market Size, 2018-2029
6.4.4 Canada Glipizide Controlled Release Tablet Market Size, 2018-2029
6.4.5 Mexico Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Glipizide Controlled Release Tablet Revenue, 2018-2029
6.5.2 By Country - Europe Glipizide Controlled Release Tablet Sales, 2018-2029
6.5.3 Germany Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.4 France Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.5 U.K. Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.6 Italy Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.7 Russia Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.8 Nordic Countries Glipizide Controlled Release Tablet Market Size, 2018-2029
6.5.9 Benelux Glipizide Controlled Release Tablet Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Glipizide Controlled Release Tablet Revenue, 2018-2029
6.6.2 By Region - Asia Glipizide Controlled Release Tablet Sales, 2018-2029
6.6.3 China Glipizide Controlled Release Tablet Market Size, 2018-2029
6.6.4 Japan Glipizide Controlled Release Tablet Market Size, 2018-2029
6.6.5 South Korea Glipizide Controlled Release Tablet Market Size, 2018-2029
6.6.6 Southeast Asia Glipizide Controlled Release Tablet Market Size, 2018-2029
6.6.7 India Glipizide Controlled Release Tablet Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Glipizide Controlled Release Tablet Revenue, 2018-2029
6.7.2 By Country - South America Glipizide Controlled Release Tablet Sales, 2018-2029
6.7.3 Brazil Glipizide Controlled Release Tablet Market Size, 2018-2029
6.7.4 Argentina Glipizide Controlled Release Tablet Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glipizide Controlled Release Tablet Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Glipizide Controlled Release Tablet Sales, 2018-2029
6.8.3 Turkey Glipizide Controlled Release Tablet Market Size, 2018-2029
6.8.4 Israel Glipizide Controlled Release Tablet Market Size, 2018-2029
6.8.5 Saudi Arabia Glipizide Controlled Release Tablet Market Size, 2018-2029
6.8.6 UAE Glipizide Controlled Release Tablet Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Glipizide Controlled Release Tablet Major Product Offerings
7.1.4 Pfizer Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Glipizide Controlled Release Tablet Major Product Offerings
7.2.4 Teva Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 NOVARTIS
7.3.1 NOVARTIS Company Summary
7.3.2 NOVARTIS Business Overview
7.3.3 NOVARTIS Glipizide Controlled Release Tablet Major Product Offerings
7.3.4 NOVARTIS Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.3.5 NOVARTIS Key News & Latest Developments
7.4 Beijing Tianan
7.4.1 Beijing Tianan Company Summary
7.4.2 Beijing Tianan Business Overview
7.4.3 Beijing Tianan Glipizide Controlled Release Tablet Major Product Offerings
7.4.4 Beijing Tianan Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.4.5 Beijing Tianan Key News & Latest Developments
7.5 Hainan Jinxiao
7.5.1 Hainan Jinxiao Company Summary
7.5.2 Hainan Jinxiao Business Overview
7.5.3 Hainan Jinxiao Glipizide Controlled Release Tablet Major Product Offerings
7.5.4 Hainan Jinxiao Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.5.5 Hainan Jinxiao Key News & Latest Developments
7.6 Shanghai Xinyi
7.6.1 Shanghai Xinyi Company Summary
7.6.2 Shanghai Xinyi Business Overview
7.6.3 Shanghai Xinyi Glipizide Controlled Release Tablet Major Product Offerings
7.6.4 Shanghai Xinyi Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.6.5 Shanghai Xinyi Key News & Latest Developments
7.7 Zhuhai Federation
7.7.1 Zhuhai Federation Company Summary
7.7.2 Zhuhai Federation Business Overview
7.7.3 Zhuhai Federation Glipizide Controlled Release Tablet Major Product Offerings
7.7.4 Zhuhai Federation Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.7.5 Zhuhai Federation Key News & Latest Developments
7.8 Changzhou Siyao Pharmaceutical
7.8.1 Changzhou Siyao Pharmaceutical Company Summary
7.8.2 Changzhou Siyao Pharmaceutical Business Overview
7.8.3 Changzhou Siyao Pharmaceutical Glipizide Controlled Release Tablet Major Product Offerings
7.8.4 Changzhou Siyao Pharmaceutical Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.8.5 Changzhou Siyao Pharmaceutical Key News & Latest Developments
7.9 Disa Pharmaceutical
7.9.1 Disa Pharmaceutical Company Summary
7.9.2 Disa Pharmaceutical Business Overview
7.9.3 Disa Pharmaceutical Glipizide Controlled Release Tablet Major Product Offerings
7.9.4 Disa Pharmaceutical Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.9.5 Disa Pharmaceutical Key News & Latest Developments
7.10 Walvax
7.10.1 Walvax Company Summary
7.10.2 Walvax Business Overview
7.10.3 Walvax Glipizide Controlled Release Tablet Major Product Offerings
7.10.4 Walvax Glipizide Controlled Release Tablet Sales and Revenue in Global (2018-2023)
7.10.5 Walvax Key News & Latest Developments
8 Global Glipizide Controlled Release Tablet Production Capacity, Analysis
8.1 Global Glipizide Controlled Release Tablet Production Capacity, 2018-2029
8.2 Glipizide Controlled Release Tablet Production Capacity of Key Manufacturers in Global Market
8.3 Global Glipizide Controlled Release Tablet Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glipizide Controlled Release Tablet Supply Chain Analysis
10.1 Glipizide Controlled Release Tablet Industry Value Chain
10.2 Glipizide Controlled Release Tablet Upstream Market
10.3 Glipizide Controlled Release Tablet Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glipizide Controlled Release Tablet Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report